Maria Thor, PhD

Assistant Attending Physicist
Maria Thor


Assistant Attending Physicist

I am an assistant attending medical physicist with a main interest in comprehensive outcome modeling to inform and encourage individualized treatments. My research focuses on radiation dose-response modeling.  I have investigated numerous different angles of individualization such as incorporation of patient-reported outcomes, inclusion of imaging information, analytes acquired from blood, and a range of patient-specific information reflecting the disease, treatment, and an individual’s underlying characteristics. My ultimate ambition is to translate my research models into updated treatment guidelines to better tailor treatments with regards to an individual’s anticipated radiation dose tolerance. I obtained my medical physics degree from Lund University (Sweden) and completed my PhD at Aarhus University (Denmark), after which I joined the Department of Medical Physics at MSK for a postdoctoral fellowship.


Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Maria Thor discloses the following relationships and financial interests:

No disclosures meeting criteria for time period

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].

View all disclosures